| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.08B | — | +111.7% |
| Cost of Revenue | $716.0M | — | +172.9% |
| R&D Expense | $104.0M | — | +48.6% |
| SG&A Expense | $164.0M | — | -6.2% |
| Operating Income | -$144.0M | — | -424.2% |
| Interest Expense | $427.0M | — | +65.9% |
| Pre-tax Income | -$656.0M | — | -144.2% |
| Income Tax | $84.0M | — | +82.5% |
| Net Income | -$740.0M | — | -135.2% |
| EPS (Basic) | -$1.40 | — | +0.0% |
| EPS (Diluted) | -$1.40 | — | +6.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.24B | -28.2% | +75.8% |
| Short-term Investments | $22.0M | -35.3% | — |
| Accounts Receivable | $2.12B | -33.1% | +100.9% |
| Current Assets | $5.61B | -25.1% | +80.8% |
| Total Assets | $55.57B | +12.7% | +154.2% |
| Current Liabilities | $17.82B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.98B | — | +4778.4% |
| Capital Expenditures | $7.70B | — | +446.8% |
| Investing Cash Flow | -$7.71B | — | -437.9% |
| Financing Cash Flow | $3.91B | — | +111.1% |
| Free Cash Flow | -$4.71B | — | -250.0% |
| +149.9% |
| Long-term Debt | $24.86B | +16.3% | +185.4% |
| Total Liabilities | $50.81B | +10.5% | +170.4% |
| Stockholders' Equity | $4.76B | +42.7% | +149.7% |